MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$28,710K
EPS
-$1.45
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue-Service Other
0
-
-
-
Total revenue-License
0
-
-
-
Total revenue
0
367
385
14,262
Research and development
22,331
16,097
17,912
19,519
General and administrative
8,606
10,147
11,743
10,127
Total operating expenses
30,937
26,244
29,655
29,646
Income (gain) from operations
-30,937
-25,877
-29,270
-15,384
Research and development incentive income
-
-
0
-
Dividend income
2,287
2,335
4,022
6,933
Other expense, net
-60
-166
273
-253
Total other income, net
2,227
2,169
4,295
6,680
Income (gain) before income taxes
-28,710
-23,708
-24,975
-8,704
Income tax (provision) benefit
0
0
-1,514
-1,424
Net income (gain)
-28,710
-23,708
-23,461
-7,280
Basic EPS
-1.45
-1.21
-0.866
-0.18
Diluted EPS
-1.45
-1.21
-0.804
-0.18
Basic Average Shares
19,800,322
19,629,906
27,089,218
40,623,364
Diluted Average Shares
19,800,322
19,629,906
29,178,828
40,623,364
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net income (gain)
-$28,710K
(6.47%↑ Y/Y)
Dividend income
$2,287K
(-67.88%↓ Y/Y)
Income (gain) before
income taxes
-$28,710K
(12.78%↑ Y/Y)
Total other income,
net
$2,227K
(-67.72%↓ Y/Y)
Other expense, net
-$60K
(72.85%↑ Y/Y)
Income (gain) from
operations
-$30,937K
(22.30%↑ Y/Y)
Total operating
expenses
$30,937K
(-46.65%↓ Y/Y)
Research and development
$22,331K
(-48.67%↓ Y/Y)
General and
administrative
$8,606K
(-40.57%↓ Y/Y)
Buy us a coffee
Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS)